nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—CA5B—cervicothoracic ganglion—systemic scleroderma	0.417	0.735	CbGeAlD
Dobutamine—Skin necrosis—Methotrexate—systemic scleroderma	0.0152	0.0351	CcSEcCtD
Dobutamine—COMT—smooth muscle tissue—systemic scleroderma	0.0143	0.0252	CbGeAlD
Dobutamine—COMT—skin of body—systemic scleroderma	0.0141	0.0249	CbGeAlD
Dobutamine—ADRB1—connective tissue—systemic scleroderma	0.0132	0.0234	CbGeAlD
Dobutamine—Ventricular extrasystoles—Mycophenolic acid—systemic scleroderma	0.0132	0.0304	CcSEcCtD
Dobutamine—Angina pectoris—Pentoxifylline—systemic scleroderma	0.0122	0.0282	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Lisinopril—systemic scleroderma	0.0119	0.0274	CcSEcCtD
Dobutamine—CA5B—tendon—systemic scleroderma	0.0117	0.0206	CbGeAlD
Dobutamine—COMT—digestive system—systemic scleroderma	0.0113	0.0199	CbGeAlD
Dobutamine—COMT—tendon—systemic scleroderma	0.0107	0.019	CbGeAlD
Dobutamine—Ventricular extrasystoles—Mycophenolate mofetil—systemic scleroderma	0.0104	0.024	CcSEcCtD
Dobutamine—CA5B—lung—systemic scleroderma	0.0102	0.0181	CbGeAlD
Dobutamine—Phlebitis—Mycophenolic acid—systemic scleroderma	0.01	0.0231	CcSEcCtD
Dobutamine—CA2—connective tissue—systemic scleroderma	0.00972	0.0171	CbGeAlD
Dobutamine—COMT—lung—systemic scleroderma	0.00943	0.0166	CbGeAlD
Dobutamine—Angina pectoris—Captopril—systemic scleroderma	0.00924	0.0213	CcSEcCtD
Dobutamine—CA2—smooth muscle tissue—systemic scleroderma	0.00889	0.0157	CbGeAlD
Dobutamine—CA2—skin of body—systemic scleroderma	0.00877	0.0155	CbGeAlD
Dobutamine—Hypokalaemia—Leflunomide—systemic scleroderma	0.00824	0.019	CcSEcCtD
Dobutamine—ADRB1—lung—systemic scleroderma	0.00799	0.0141	CbGeAlD
Dobutamine—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.00791	0.0183	CcSEcCtD
Dobutamine—Hypokalaemia—Mycophenolic acid—systemic scleroderma	0.00786	0.0181	CcSEcCtD
Dobutamine—Palpitations—Pentoxifylline—systemic scleroderma	0.00771	0.0178	CcSEcCtD
Dobutamine—Angina pectoris—Leflunomide—systemic scleroderma	0.00762	0.0176	CcSEcCtD
Dobutamine—Chest pain—Pentoxifylline—systemic scleroderma	0.00743	0.0171	CcSEcCtD
Dobutamine—Angina pectoris—Mycophenolic acid—systemic scleroderma	0.00727	0.0168	CcSEcCtD
Dobutamine—CA2—digestive system—systemic scleroderma	0.00702	0.0124	CbGeAlD
Dobutamine—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00697	0.0161	CcSEcCtD
Dobutamine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00695	0.016	CcSEcCtD
Dobutamine—CA2—tendon—systemic scleroderma	0.00668	0.0118	CbGeAlD
Dobutamine—Hypotension—Pentoxifylline—systemic scleroderma	0.00665	0.0154	CcSEcCtD
Dobutamine—Angina pectoris—Lisinopril—systemic scleroderma	0.00655	0.0151	CcSEcCtD
Dobutamine—Chest pain—Mometasone—systemic scleroderma	0.00641	0.0148	CcSEcCtD
Dobutamine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00635	0.0147	CcSEcCtD
Dobutamine—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.0062	0.0143	CcSEcCtD
Dobutamine—Skin exfoliation—Prednisone—systemic scleroderma	0.00607	0.014	CcSEcCtD
Dobutamine—CA2—lung—systemic scleroderma	0.00586	0.0103	CbGeAlD
Dobutamine—Palpitations—Captopril—systemic scleroderma	0.00584	0.0135	CcSEcCtD
Dobutamine—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.00574	0.0132	CcSEcCtD
Dobutamine—Chest pain—Captopril—systemic scleroderma	0.00563	0.013	CcSEcCtD
Dobutamine—Dyspnoea—Mometasone—systemic scleroderma	0.00548	0.0126	CcSEcCtD
Dobutamine—Thrombocytopenia—Captopril—systemic scleroderma	0.00528	0.0122	CcSEcCtD
Dobutamine—Tachycardia—Captopril—systemic scleroderma	0.00527	0.0122	CcSEcCtD
Dobutamine—Skin exfoliation—Methotrexate—systemic scleroderma	0.00508	0.0117	CcSEcCtD
Dobutamine—Hypotension—Captopril—systemic scleroderma	0.00504	0.0116	CcSEcCtD
Dobutamine—Pruritus—Pentoxifylline—systemic scleroderma	0.00504	0.0116	CcSEcCtD
Dobutamine—Palpitations—Leflunomide—systemic scleroderma	0.00482	0.0111	CcSEcCtD
Dobutamine—Dyspnoea—Captopril—systemic scleroderma	0.00481	0.0111	CcSEcCtD
Dobutamine—Chest pain—Leflunomide—systemic scleroderma	0.00464	0.0107	CcSEcCtD
Dobutamine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00461	0.0106	CcSEcCtD
Dobutamine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00459	0.0106	CcSEcCtD
Dobutamine—Headache—Pentoxifylline—systemic scleroderma	0.00446	0.0103	CcSEcCtD
Dobutamine—Chest pain—Mycophenolic acid—systemic scleroderma	0.00443	0.0102	CcSEcCtD
Dobutamine—Hypotension—Azathioprine—systemic scleroderma	0.0044	0.0102	CcSEcCtD
Dobutamine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00436	0.0101	CcSEcCtD
Dobutamine—Pruritus—Mometasone—systemic scleroderma	0.00435	0.01	CcSEcCtD
Dobutamine—Tachycardia—Leflunomide—systemic scleroderma	0.00434	0.01	CcSEcCtD
Dobutamine—Nausea—Pentoxifylline—systemic scleroderma	0.00423	0.00976	CcSEcCtD
Dobutamine—Hypokalaemia—Prednisone—systemic scleroderma	0.0042	0.0097	CcSEcCtD
Dobutamine—Hypotension—Leflunomide—systemic scleroderma	0.00416	0.00959	CcSEcCtD
Dobutamine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00415	0.00959	CcSEcCtD
Dobutamine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00414	0.00956	CcSEcCtD
Dobutamine—Palpitations—Lisinopril—systemic scleroderma	0.00414	0.00955	CcSEcCtD
Dobutamine—Chest pain—Lisinopril—systemic scleroderma	0.00399	0.0092	CcSEcCtD
Dobutamine—Dyspnoea—Leflunomide—systemic scleroderma	0.00397	0.00915	CcSEcCtD
Dobutamine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00397	0.00915	CcSEcCtD
Dobutamine—Headache—Mometasone—systemic scleroderma	0.00385	0.00889	CcSEcCtD
Dobutamine—Pruritus—Captopril—systemic scleroderma	0.00382	0.00881	CcSEcCtD
Dobutamine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00378	0.00873	CcSEcCtD
Dobutamine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00374	0.00864	CcSEcCtD
Dobutamine—Tachycardia—Lisinopril—systemic scleroderma	0.00373	0.00861	CcSEcCtD
Dobutamine—Nausea—Mometasone—systemic scleroderma	0.00365	0.00843	CcSEcCtD
Dobutamine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00363	0.00837	CcSEcCtD
Dobutamine—Hypotension—Lisinopril—systemic scleroderma	0.00357	0.00824	CcSEcCtD
Dobutamine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00349	0.00806	CcSEcCtD
Dobutamine—Dyspnoea—Lisinopril—systemic scleroderma	0.00341	0.00787	CcSEcCtD
Dobutamine—Headache—Captopril—systemic scleroderma	0.00338	0.0078	CcSEcCtD
Dobutamine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00328	0.00757	CcSEcCtD
Dobutamine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00327	0.00754	CcSEcCtD
Dobutamine—Nausea—Captopril—systemic scleroderma	0.00321	0.0074	CcSEcCtD
Dobutamine—Pruritus—Leflunomide—systemic scleroderma	0.00315	0.00726	CcSEcCtD
Dobutamine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00313	0.00722	CcSEcCtD
Dobutamine—Pruritus—Mycophenolic acid—systemic scleroderma	0.003	0.00693	CcSEcCtD
Dobutamine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00299	0.00689	CcSEcCtD
Dobutamine—Headache—Azathioprine—systemic scleroderma	0.00295	0.00681	CcSEcCtD
Dobutamine—Nausea—Azathioprine—systemic scleroderma	0.0028	0.00646	CcSEcCtD
Dobutamine—Headache—Leflunomide—systemic scleroderma	0.00279	0.00643	CcSEcCtD
Dobutamine—Pruritus—Lisinopril—systemic scleroderma	0.0027	0.00624	CcSEcCtD
Dobutamine—Headache—Mycophenolic acid—systemic scleroderma	0.00266	0.00614	CcSEcCtD
Dobutamine—Nausea—Leflunomide—systemic scleroderma	0.00264	0.0061	CcSEcCtD
Dobutamine—Nausea—Mycophenolic acid—systemic scleroderma	0.00252	0.00582	CcSEcCtD
Dobutamine—Headache—Lisinopril—systemic scleroderma	0.00239	0.00553	CcSEcCtD
Dobutamine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00547	CcSEcCtD
Dobutamine—Nausea—Lisinopril—systemic scleroderma	0.00227	0.00524	CcSEcCtD
Dobutamine—Tachycardia—Prednisone—systemic scleroderma	0.00222	0.00511	CcSEcCtD
Dobutamine—Headache—Mycophenolate mofetil—systemic scleroderma	0.0021	0.00484	CcSEcCtD
Dobutamine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00459	CcSEcCtD
Dobutamine—Chest pain—Methotrexate—systemic scleroderma	0.00198	0.00457	CcSEcCtD
Dobutamine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00186	0.00429	CcSEcCtD
Dobutamine—Hypotension—Methotrexate—systemic scleroderma	0.00177	0.00409	CcSEcCtD
Dobutamine—Dyspnoea—Methotrexate—systemic scleroderma	0.00169	0.0039	CcSEcCtD
Dobutamine—Pruritus—Prednisone—systemic scleroderma	0.00161	0.00371	CcSEcCtD
Dobutamine—Headache—Prednisone—systemic scleroderma	0.00142	0.00328	CcSEcCtD
Dobutamine—Nausea—Prednisone—systemic scleroderma	0.00135	0.00311	CcSEcCtD
Dobutamine—Pruritus—Methotrexate—systemic scleroderma	0.00134	0.0031	CcSEcCtD
Dobutamine—Headache—Methotrexate—systemic scleroderma	0.00119	0.00274	CcSEcCtD
Dobutamine—Nausea—Methotrexate—systemic scleroderma	0.00113	0.0026	CcSEcCtD
